Genexine Financial Statements From 2010 to 2024
Genexine financial statements provide useful quarterly and yearly information to potential Genexine investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genexine financial statements helps investors assess Genexine's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genexine's valuation are summarized below:Genexine does not presently have any fundamental trends for analysis.
This module can also supplement various Genexine Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Check Genexine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genexine's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genexine financial statements analysis is a perfect complement when working with Genexine Valuation or Volatility modules.
Genexine |
Genexine Company Current Valuation Analysis
Genexine's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Genexine Current Valuation | 2.14 T |
Most of Genexine's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genexine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Genexine has a Current Valuation of 2.14 T. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
Genexine Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genexine's current stock value. Our valuation model uses many indicators to compare Genexine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genexine competition to find correlations between indicators driving Genexine's intrinsic value. More Info.Genexine is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genexine by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genexine's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Pair Trading with Genexine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genexine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genexine will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Genexine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genexine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genexine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genexine to buy it.
The correlation of Genexine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genexine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genexine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genexine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Genexine Stock
Genexine financial ratios help investors to determine whether Genexine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genexine with respect to the benefits of owning Genexine security.